Incannex Healthcare Files 8-K
Ticker: IXHL · Form: 8-K · Filed: May 30, 2024 · CIK: 1873875
| Field | Detail |
|---|---|
| Company | Incannex Healthcare Inc. (IXHL) |
| Form Type | 8-K |
| Filed Date | May 30, 2024 |
| Risk Level | low |
| Pages | 1 |
| Reading Time | 2 min |
| Key Dollar Amounts | $0.0001 |
| Sentiment | neutral |
Sentiment: neutral
Topics: sec-filing, 8-k, corporate-update
TL;DR
INCANNEX HEALTHCARE FILES 8-K WITH SEC - INVESTORS CHECK FOR UPDATES.
AI Summary
Incannex Healthcare Inc. filed an 8-K on May 30, 2024, to report other events and financial statements. The company, incorporated in Delaware, is based in Docklands, Victoria, Australia, and operates in the pharmaceutical preparations sector. This filing serves as a current report under the Securities Exchange Act of 1934.
Why It Matters
This 8-K filing indicates Incannex Healthcare Inc. is providing updates on its corporate activities and financial status to the SEC, which is important for investors to monitor.
Risk Assessment
Risk Level: low — This filing is a routine disclosure of corporate events and financial information, not indicating any immediate operational or financial distress.
Key Players & Entities
- Incannex Healthcare Inc. (company) — Registrant
- May 30, 2024 (date) — Date of Report
- 001-41106 (company) — Commission File Number
- 93-2403210 (company) — IRS Employer Identification No.
- Australia (company) — Principal Executive Offices Location
FAQ
What is the primary purpose of this 8-K filing for Incannex Healthcare Inc.?
The primary purpose is to report 'Other Events' and 'Financial Statements and Exhibits' as a current report under Section 13 or 15(d) of the Securities Exchange Act of 1934.
When was this 8-K filing submitted to the SEC?
The filing was submitted on May 30, 2024.
What is Incannex Healthcare Inc.'s Commission File Number?
Incannex Healthcare Inc.'s Commission File Number is 001-41106.
Where are Incannex Healthcare Inc.'s principal executive offices located?
The principal executive offices are located in Norwest, NSW, Australia.
What is the Standard Industrial Classification (SIC) code for Incannex Healthcare Inc.?
The SIC code for Incannex Healthcare Inc. is 2834, which corresponds to Pharmaceutical Preparations.
Filing Stats: 439 words · 2 min read · ~1 pages · Grade level 11 · Accepted 2024-05-30 08:30:34
Key Financial Figures
- $0.0001 — nge on which registered Common Stock, $0.0001 par value per share IXHL The Nasdaq
Filing Documents
- ea0207080-8k_incannex.htm (8-K) — 27KB
- ea020708001ex99-1_incannex.htm (EX-99.1) — 21KB
- ex99-1_001.jpg (GRAPHIC) — 4KB
- 0001213900-24-047708.txt ( ) — 230KB
- ixhl-20240530.xsd (EX-101.SCH) — 3KB
- ixhl-20240530_lab.xml (EX-101.LAB) — 33KB
- ixhl-20240530_pre.xml (EX-101.PRE) — 22KB
- ea0207080-8k_incannex_htm.xml (XML) — 4KB
01
Item 8.01 On May 30, 2024, Incannex Healthcare Inc. announced that it has commenced dosing in the RePOSA Phase 2/3 Clinical Trial Protocol to Assess IHL-42X Drug in Patients with Obstructive Sleep Apnea. Further information is included in the press release attached as Exhibit 99.1 hereto, which is incorporated by reference into this Item 8.01.
01 Financial Statements and Exhibits
Item 9.01 Financial Statements and Exhibits. (d) Exhibits Exhibit No. Description 99.1 Press Release of Incannex Healthcare Inc., dated May 30, 2024. 104 Cover Page Interactive Data File (embedded within the Inline XBRL document) 1
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Incannex Healthcare Inc. Date: May 30, 2024 /s/ Joel Latham Name: Joel Latham Title: Chief Executive Officer and President 2